These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 11073163

  • 21. [Mechanism of G2/M cell cycle arrest before apoptosis in leukemia cell line HL-60 induced by proteasome inhibitor MG132].
    Sun GJ, Qian JJ, Meng XB, Song Y, Zhang F, Mei ZZ, Dong Y, Sun ZX.
    Ai Zheng; 2004 Oct; 23(10):1144-8. PubMed ID: 15473924
    [Abstract] [Full Text] [Related]

  • 22. Induction of G1 arrest and selective growth inhibition by lactacystin in human umbilical vein endothelial cells.
    Kumeda SI, Deguchi A, Toi M, Omura S, Umezawa K.
    Anticancer Res; 1999 Oct; 19(5B):3961-8. PubMed ID: 10628338
    [Abstract] [Full Text] [Related]

  • 23. Mechanisms of proteasome inhibitor PS-341-induced G(2)-M-phase arrest and apoptosis in human non-small cell lung cancer cell lines.
    Ling YH, Liebes L, Jiang JD, Holland JF, Elliott PJ, Adams J, Muggia FM, Perez-Soler R.
    Clin Cancer Res; 2003 Mar; 9(3):1145-54. PubMed ID: 12631620
    [Abstract] [Full Text] [Related]

  • 24. Lactacystin, a specific inhibitor of the proteasome, induces apoptosis and activates caspase-3 in cultured cerebellar granule cells.
    Pasquini LA, Besio Moreno M, Adamo AM, Pasquini JM, Soto EF.
    J Neurosci Res; 2000 Mar 01; 59(5):601-11. PubMed ID: 10686588
    [Abstract] [Full Text] [Related]

  • 25. Proteasome-mediated degradation of cell division cycle 25C and cyclin-dependent kinase 1 in phenethyl isothiocyanate-induced G2-M-phase cell cycle arrest in PC-3 human prostate cancer cells.
    Xiao D, Johnson CS, Trump DL, Singh SV.
    Mol Cancer Ther; 2004 May 01; 3(5):567-75. PubMed ID: 15141014
    [Abstract] [Full Text] [Related]

  • 26. Apoptosis induction resulting from proteasome inhibition.
    Shinohara K, Tomioka M, Nakano H, Toné S, Ito H, Kawashima S.
    Biochem J; 1996 Jul 15; 317 ( Pt 2)(Pt 2):385-8. PubMed ID: 8713062
    [Abstract] [Full Text] [Related]

  • 27. Proteasome-dependent regulation of p21WAF1/CIP1 expression.
    Blagosklonny MV, Wu GS, Omura S, el-Deiry WS.
    Biochem Biophys Res Commun; 1996 Oct 14; 227(2):564-9. PubMed ID: 8878553
    [Abstract] [Full Text] [Related]

  • 28. Pro-caspase-3 overexpression sensitises ovarian cancer cells to proteasome inhibitors.
    Tenev T, Marani M, McNeish I, Lemoine NR.
    Cell Death Differ; 2001 Mar 14; 8(3):256-64. PubMed ID: 11319608
    [Abstract] [Full Text] [Related]

  • 29. Ubiquitin/proteasome-dependent degradation of D-type cyclins is linked to tumor necrosis factor-induced cell cycle arrest.
    Hu X, Bryington M, Fisher AB, Liang X, Zhang X, Cui D, Datta I, Zuckerman KS.
    J Biol Chem; 2002 May 10; 277(19):16528-37. PubMed ID: 11864973
    [Abstract] [Full Text] [Related]

  • 30. Preferential induction of apoptosis for primary human leukemic stem cells.
    Guzman ML, Swiderski CF, Howard DS, Grimes BA, Rossi RM, Szilvassy SJ, Jordan CT.
    Proc Natl Acad Sci U S A; 2002 Dec 10; 99(25):16220-5. PubMed ID: 12451177
    [Abstract] [Full Text] [Related]

  • 31. Apoptosis induced in hepatoblastoma HepG2 cells by the proteasome inhibitor MG132 is associated with hydrogen peroxide production, expression of Bcl-XS and activation of caspase-3.
    Emanuele S, Calvaruso G, Lauricella M, Giuliano M, Bellavia G, D'Anneo A, Vento R, Tesoriere G.
    Int J Oncol; 2002 Oct 10; 21(4):857-65. PubMed ID: 12239627
    [Abstract] [Full Text] [Related]

  • 32. The apoptotic effects and synergistic interaction of sodium butyrate and MG132 in human retinoblastoma Y79 cells.
    Giuliano M, Lauricella M, Calvaruso G, Carabillò M, Emanuele S, Vento R, Tesoriere G.
    Cancer Res; 1999 Nov 01; 59(21):5586-95. PubMed ID: 10554039
    [Abstract] [Full Text] [Related]

  • 33. The cyclin-dependent kinase inhibitor flavopiridol disrupts sodium butyrate-induced p21WAF1/CIP1 expression and maturation while reciprocally potentiating apoptosis in human leukemia cells.
    Rosato RR, Almenara JA, Cartee L, Betts V, Chellappan SP, Grant S.
    Mol Cancer Ther; 2002 Feb 01; 1(4):253-66. PubMed ID: 12467221
    [Abstract] [Full Text] [Related]

  • 34. Concomitant differentiation and partial proteasome inhibition trigger apoptosis in neuroblastoma cells.
    Nahreini P, Andreatta C, Hanson A, Prasad KN.
    J Neurooncol; 2003 May 01; 63(1):15-23. PubMed ID: 12814250
    [Abstract] [Full Text] [Related]

  • 35. The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21CIP1/WAF1 1.
    Rosato RR, Almenara JA, Grant S.
    Cancer Res; 2003 Jul 01; 63(13):3637-45. PubMed ID: 12839953
    [Abstract] [Full Text] [Related]

  • 36. Proteasome inhibitor-induced apoptosis of glioma cells involves the processing of multiple caspases and cytochrome c release.
    Wagenknecht B, Hermisson M, Groscurth P, Liston P, Krammer PH, Weller M.
    J Neurochem; 2000 Dec 01; 75(6):2288-97. PubMed ID: 11080180
    [Abstract] [Full Text] [Related]

  • 37. Cladribine induces apoptosis in human leukaemia cells by caspase-dependent and -independent pathways acting on mitochondria.
    Marzo I, Pérez-Galán P, Giraldo P, Rubio-Félix D, Anel A, Naval J.
    Biochem J; 2001 Nov 01; 359(Pt 3):537-46. PubMed ID: 11672427
    [Abstract] [Full Text] [Related]

  • 38. Induction of apoptosis by the proteasome inhibitor MG132 in human HCC cells: Possible correlation with specific caspase-dependent cleavage of beta-catenin and inhibition of beta-catenin-mediated transactivation.
    Cervello M, Giannitrapani L, La Rosa M, Notarbartolo M, Labbozzetta M, Poma P, Montalto G, D'Alessandro N.
    Int J Mol Med; 2004 May 01; 13(5):741-8. PubMed ID: 15067380
    [Abstract] [Full Text] [Related]

  • 39. 7-Hydroxystaurosporine (UCN-01) induces apoptosis in human colon carcinoma and leukemia cells independently of p53.
    Shao RG, Shimizu T, Pommier Y.
    Exp Cell Res; 1997 Aug 01; 234(2):388-97. PubMed ID: 9260909
    [Abstract] [Full Text] [Related]

  • 40. Potential of the proteasomal inhibitor MG-132 as an anticancer agent, alone and in combination.
    Banerjee D, Liefshitz A.
    Anticancer Res; 2001 Aug 01; 21(6A):3941-7. PubMed ID: 11911275
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.